Protea, Mass General Partner on Cancer Immunotherapy Tests – GenomeWeb
WeeklyHub |
Protea, Mass General Partner on Cancer Immunotherapy Tests
GenomeWeb Under the terms of the deal, Protea will work with MGH's Vaccine and Immunotherapy Center to develop a diagnostic methodology for obtaining cancer cell molecular profiles, including the distribution of drugs within cancer cells and molecular response … Protea Announces Research Agreement with Mass General Hospital |
